Jason M Gauthier1, Andrew J Bierhals2, Jingxia Liu3, Keki R Balsara4, Christine Frederiksen1, Emily Gremminger1, Ramsey R Hachem5, Chad A Witt5, Elbert P Trulock5, Derek E Byers5, Roger D Yusen5, Patrick R Aguilar5, Gary Marklin6, Ruben G Nava1, Benjamin D Kozower1, Michael K Pasque1, Bryan F Meyers1, G Alexander Patterson1, Daniel Kreisel7, Varun Puri8. 1. Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Miss. 2. Division of Diagnostic Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Miss. 3. Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Miss. 4. Department of Cardiac Surgery, Vanderbilt University School of Medicine, Nashville, Tenn. 5. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St Louis, Miss. 6. Mid-America Transplant, Washington University School of Medicine, St Louis, Miss. 7. Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Miss; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Mo. 8. Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Miss. Electronic address: varunpuri@wustl.edu.
Abstract
OBJECTIVE: Chest computed tomography (CT) imaging is being increasingly used for potential lung donor assessment. However, the efficacy of CT imaging in this setting remains unknown. We hypothesize that chest CT imaging independently affects the decision-making process in donor lung utilization. METHODS: We conducted a retrospective cohort study of all adult donation after brain death donors managed through our local organ procurement organization from June 2011 to November 2016. An experienced thoracic radiologist independently reviewed donor chest CT and chest x-ray images in a blinded, standardized manner to determine the presence of structural lung disease (eg, emphysema, interstitial lung disease [ILD]) and acute abnormalities (eg, traumatic lung injury [TLI]). Distinct models of lung utilization were fit to groups with initial partial pressure of oxygen (iPaO2) ≤300 mm Hg (suboptimal) and iPaO2 >300 mm Hg (optimal). RESULTS: The organ procurement organization managed 753 donors during the study period, with a lung utilization rate ([lung donors/all organ donors] × 100) of 36.5% (275 of 753). Four hundred forty-five (59.1%) donors received chest CT imaging, revealing emphysema (13.7%), ILD (2.5%), and TLI (7.2%). In univariate analysis, findings of TLI (odds ratio [OR], 2.23; 95% confidence interval [CI], 1.08-4.61) were positively associated with lung utilization, whereas findings of emphysema (OR, 0.18; CI, 0.08-0.40) were negatively associated with utilization. In multivariate analysis, CT findings of emphysema (OR, 0.21; CI 0.08-0.54) remained negatively associated with utilization. No potential donors with CT findings of ILD became lung donors. After controlling for chest x-ray findings, chest CT imaging findings of structural lung disease remained negatively associated with utilization (P = .0001). Lung utilization rate in the suboptimal and optimal iPaO2 populations was 35.1% and 41.4%, respectively, and CT findings of emphysema had a significant association with nonutilization in both groups. CONCLUSIONS: In the evaluation of potential lung donors, chest CT imaging findings of structural lung disease, such as emphysema and ILD, have a significant negative association with lung utilization. Our findings suggest that chest CT imaging might be an important adjunct to conventional lung donor assessment criteria.
OBJECTIVE: Chest computed tomography (CT) imaging is being increasingly used for potential lung donor assessment. However, the efficacy of CT imaging in this setting remains unknown. We hypothesize that chest CT imaging independently affects the decision-making process in donor lung utilization. METHODS: We conducted a retrospective cohort study of all adult donation after brain death donors managed through our local organ procurement organization from June 2011 to November 2016. An experienced thoracic radiologist independently reviewed donor chest CT and chest x-ray images in a blinded, standardized manner to determine the presence of structural lung disease (eg, emphysema, interstitial lung disease [ILD]) and acute abnormalities (eg, traumatic lung injury [TLI]). Distinct models of lung utilization were fit to groups with initial partial pressure of oxygen (iPaO2) ≤300 mm Hg (suboptimal) and iPaO2 >300 mm Hg (optimal). RESULTS: The organ procurement organization managed 753 donors during the study period, with a lung utilization rate ([lung donors/all organ donors] × 100) of 36.5% (275 of 753). Four hundred forty-five (59.1%) donors received chest CT imaging, revealing emphysema (13.7%), ILD (2.5%), and TLI (7.2%). In univariate analysis, findings of TLI (odds ratio [OR], 2.23; 95% confidence interval [CI], 1.08-4.61) were positively associated with lung utilization, whereas findings of emphysema (OR, 0.18; CI, 0.08-0.40) were negatively associated with utilization. In multivariate analysis, CT findings of emphysema (OR, 0.21; CI 0.08-0.54) remained negatively associated with utilization. No potential donors with CT findings of ILD became lung donors. After controlling for chest x-ray findings, chest CT imaging findings of structural lung disease remained negatively associated with utilization (P = .0001). Lung utilization rate in the suboptimal and optimal iPaO2 populations was 35.1% and 41.4%, respectively, and CT findings of emphysema had a significant association with nonutilization in both groups. CONCLUSIONS: In the evaluation of potential lung donors, chest CT imaging findings of structural lung disease, such as emphysema and ILD, have a significant negative association with lung utilization. Our findings suggest that chest CT imaging might be an important adjunct to conventional lung donor assessment criteria.
Authors: Robert S Bonser; Rhiannon Taylor; David Collett; Helen L Thomas; John H Dark; James Neuberger Journal: Lancet Date: 2012-05-29 Impact factor: 79.321
Authors: S Sundaresan; J Semenkovich; L Ochoa; G Richardson; E P Trulock; J D Cooper; G A Patterson Journal: J Thorac Cardiovasc Surg Date: 1995-06 Impact factor: 5.209
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: M Valapour; M A Skeans; J M Smith; L B Edwards; W S Cherikh; K Uccellini; A K Israni; J J Snyder; B L Kasiske Journal: Am J Transplant Date: 2017-01 Impact factor: 8.086
Authors: Wesley H Self; D Mark Courtney; Candace D McNaughton; Richard G Wunderink; Jeffrey A Kline Journal: Am J Emerg Med Date: 2012-10-18 Impact factor: 2.469
Authors: Francis T Delaney; John G Murray; Barry D Hutchinson; Jim J Egan; Michelle Murray; Sara Winward; Nicola Ronan; Carmel G Cronin Journal: Eur Radiol Date: 2022-06-16 Impact factor: 5.315
Authors: Christian Corbin Frye; Jason M Gauthier; Amit Bery; William D Gerull; Deniz B Morkan; Jingxia Liu; M Shea Harrison; Yuriko Terada; Judith E Van Zanden; Gary F Marklin; Michael K Pasque; Ruben G Nava; Bryan F Meyers; Alexander G Patterson; Benjamin D Kozower; Ramsey Hachem; Derek Byers; Chad Witt; Hrishikesh Kulkarni; Daniel Kreisel; Varun Puri Journal: Clin Transplant Date: 2020-12-14 Impact factor: 2.863
Authors: Amit Bery; Gary Marklin; Akinobu Itoh; Daniel Kreisel; Tsuyoshi Takahashi; Bryan F Meyers; Ruben Nava; Benjamin D Kozower; Hailey Shepherd; G Alexander Patterson; Varun Puri Journal: Ann Thorac Surg Date: 2021-01-07 Impact factor: 5.102
Authors: Yuriko Terada; Jason M Gauthier; Michael K Pasque; Tsuyoshi Takahashi; Jingxia Liu; Ruben G Nava; Ramsey R Hachem; Chad A Witt; Derek E Byers; Rodrigo Vazquez Guillamet; Benjamin D Kozower; Bryan F Meyers; Patrick R Aguilar; Hrishikesh S Kulkarni; G Alexander Patterson; Daniel Kreisel; Varun Puri Journal: Ann Thorac Surg Date: 2020-10-22 Impact factor: 5.102
Authors: Satona Tanaka; Jason M Gauthier; Yuriko Terada; Tsuyoshi Takahashi; Wenjun Li; Kohei Hashimoto; Ryuji Higashikubo; Ramsey R Hachem; Ankit Bharat; Jon H Ritter; Ruben G Nava; Varun Puri; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel Journal: Am J Transplant Date: 2020-09-05 Impact factor: 8.086